Identification of replication factor C subunit 4 as a potential therapeutic target in esophageal squamous cell carcinoma based on bioinformatic analysis and machine learning
Open Access
- 22 May 2026
- journal article
- Published by Springer Nature in Discover Oncology
- Vol. 17 (1)
Abstract
Esophageal squamous cell carcinoma (ESCC) is one of the highly lethal and aggressive malignant tumors worldwide. To effectively prevent and treat this disease, the search for novel molecular targets is of great significance for promoting the molecular diagnosis and targeted therapy of ESCC. Gene expression profiles from gene expression omnibus (GEO) datasets were normalized and analyzed to identify differentially expressed genes. Functional enrichment, protein-protein interaction network, and machine learning algorithms were applied for biomarker screening. Immune infiltration analysis and immunohistochemistry were performed to assess clinical relevance. Analysis identified 752 differentially expressed genes in ESCC, with enrichment in upregulated pathways including DNA replication and mismatch repair, and downregulated pathways such as autophagy. Gene Ontology/Kyoto Encyclopedia of Genes and Genomes analyses revealed complex molecular networks driving ESCC. Key hub genes and diagnostic biomarkers aurora kinase A (AURKA), kinesin family member 4 A (KIF4A), and replication factor C subunit 4 (RFC4) were identified, with high diagnostic area under the receiver operating characteristic curve values from 0.976 to 0.983. RFC4 expression correlated with mast cell infiltration patterns, showed elevated expression in ESCC tissues via immunohistochemistry, and was associated with poor prognosis. This study identifies AURKA, KIF4A, and RFC4 as potential in silico biomarkers for ESCC. This study further highlights RFC4 as a promising candidate for diagnostic and prognostic applications, offering new insights into prevention strategies for ESCC.Keywords
Funding Information
- Henan Province Medical Science and Technology Research Program Joint Construction Project (LHGJ20240878)
- Key Scientific Research Projects of Colleges and Universities in Henan Province (26B310010)
This publication has 53 references indexed in Scilit:
- Spatio‐Temporal Proteomic Landscape Reveals Early Warning Signals of Esophageal Squamous Cell Carcinoma ProgressionAdvanced Science, 2026
- Cloud‐Based GWAS Platform: An Innovative Solution for Efficient Acquisition and Analysis of Genomic DataMed Research, 2025
- Integrating network pharmacology and molecular modeling to decipher the anti-esophageal squamous cell carcinoma mechanisms of Bidens pilosa LDiscover Oncology, 2025
- Knockdown of RFC 4 inhibits cell proliferation of oral squamous cell carcinoma in vitro and in vivoFEBS Open Bio, 2024
- CircMALAT1 promotes cancer stem‐like properties and chemoresistance via regulating Musashi‐2/c‐Myc axis in esophageal squamous cell carcinomaMedcomm, 2024
- Knockdown of RFC4 inhibits the cell proliferation of nasopharyngeal carcinoma in vitro and in vivoFrontiers of Medicine, 2022
- KIF4A promotes genomic stability and progression of endometrial cancer through regulation of TPX2 protein degradationMolecular Carcinogenesis, 2022
- AURKA is a prognostic potential therapeutic target in skin cutaneous melanoma modulating the tumor microenvironment, apoptosis, and hypoxiaJournal of Cancer Research and Clinical Oncology, 2022
- YAP/TEAD4‐induced KIF4A contributes to the progression and worse prognosis of esophageal squamous cell carcinomaMolecular Carcinogenesis, 2021
- Epidemiology of esophageal cancer: update in global trends, etiology and risk factorsClinical Journal of Gastroenterology, 2020